Is Semaglutide Legal? FDA Status, Prescription & Compounding

Current regulatory status of Semaglutide in the United States: FDA approval, Section 503A compounding eligibility, prescription requirements, and WADA anti-doping status.

Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.

FDA Status
FDA Approved
Approved for: Type 2 diabetes (Ozempic, Rybelsus), Chronic weight management (Wegovy), Cardiovascular risk reduction (Wegovy)
WADA Status
Not Listed
Not on current Prohibited List

FDA Regulatory Status

FDA-approved GLP-1 receptor agonist. Ozempic approved for type 2 diabetes (2017). Wegovy approved for chronic weight management (2021) and cardiovascular risk reduction (2024).

Source: PeptideMark FDA Peptide Tracker — compiled from FDA.gov bulk substances guidance and 503A nominations.

Prescription & Legal Access

Semaglutide is a prescription-only medication in the U.S. It must be prescribed by a licensed healthcare provider and dispensed through a licensed pharmacy. Off-label prescribing is at the provider's discretion within their scope of practice. Any source selling Semaglutide without a prescription is operating outside FDA regulations.

Section 503A Compounding

Section 503A of the Federal Food, Drug, and Cosmetic Act governs which substances compounding pharmacies may use. Substances are placed into one of three categories: Category 1 (eligible for compounding), Category 2 (significant safety concerns — prohibited), or Category 3 (under review).

Current Semaglutide category:
Not governed by 503A for standard approved indications. Compounding permitted only in limited cases where the commercial product cannot meet a patient-specific need.

WADA & Anti-Doping Status

Semaglutide is not currently listed on the WADA Prohibited List. However, WADA updates its list annually, and substances may be added under the catch-all "S0 Non-Approved Substances" clause if they have no current approval for human therapeutic use. Athletes should check the current WADA Prohibited List before use.

Frequently Asked Questions

Is Semaglutide FDA approved?

Yes. Semaglutide is FDA approved for Type 2 diabetes (Ozempic, Rybelsus), Chronic weight management (Wegovy), Cardiovascular risk reduction (Wegovy). Any other use is considered off-label.

Do I need a prescription for Semaglutide?

Yes. Semaglutide is a prescription-only medication in the United States. It must be obtained from a licensed pharmacy with a valid prescription from a qualified healthcare provider.

Can compounding pharmacies make Semaglutide?

Compounding of Semaglutide is generally restricted to scenarios where a commercially available FDA-approved product cannot meet a specific patient need. Routine compounding for convenience is not permitted under Section 503A.

Is Semaglutide banned by WADA?

Semaglutide is not currently listed on the WADA Prohibited List as of the most recent revision. Athletes should always check the current list before use, as WADA updates it annually.

Is it legal to buy Semaglutide online?

Products marketed as "Semaglutide for research use only" are widely sold online but are not authorized for human consumption. Purchasing these products for personal use may violate FDA regulations and carries significant quality, purity, and legal risk. There is no FDA-sanctioned retail pathway for non-prescription human use.

Continue Reading